276 related articles for article (PubMed ID: 24811243)
1. Poly(amidoamine) dendrimer nanocarriers and their aerosol formulations for siRNA delivery to the lung epithelium.
Conti DS; Brewer D; Grashik J; Avasarala S; da Rocha SR
Mol Pharm; 2014 Jun; 11(6):1808-22. PubMed ID: 24811243
[TBL] [Abstract][Full Text] [Related]
2. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
[TBL] [Abstract][Full Text] [Related]
3. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.
Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP
Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811
[TBL] [Abstract][Full Text] [Related]
4. Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.
Zhong Q; Merkel OM; Reineke JJ; da Rocha SR
Mol Pharm; 2016 Jun; 13(6):1866-78. PubMed ID: 27148629
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model.
Bohr A; Tsapis N; Foged C; Andreana I; Yang M; Fattal E
Eur J Pharm Biopharm; 2020 Nov; 156():114-120. PubMed ID: 32798665
[TBL] [Abstract][Full Text] [Related]
6. Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes.
Golkar N; Samani SM; Tamaddon AM
Int J Pharm; 2016 Aug; 510(1):30-41. PubMed ID: 27291973
[TBL] [Abstract][Full Text] [Related]
7. Poly(amidoamine) Dendrimer-Doxorubicin Conjugates: In Vitro Characteristics and Pseudosolution Formulation in Pressurized Metered-Dose Inhalers.
Zhong Q; da Rocha SR
Mol Pharm; 2016 Mar; 13(3):1058-72. PubMed ID: 26832992
[TBL] [Abstract][Full Text] [Related]
8. Propellant-based inhalers for the non-invasive delivery of genes via oral inhalation.
Conti DS; Bharatwaj B; Brewer D; da Rocha SR
J Control Release; 2012 Feb; 157(3):406-17. PubMed ID: 21982899
[TBL] [Abstract][Full Text] [Related]
9. Cellular internalization and transport of biodegradable polyester dendrimers on a model of the pulmonary epithelium and their formulation in pressurized metered-dose inhalers.
Heyder RS; Zhong Q; Bazito RC; da Rocha SRP
Int J Pharm; 2017 Mar; 520(1-2):181-194. PubMed ID: 28161666
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing polycation/siRNA colloidal stability toward aerosol lung delivery.
Steele TW; Zhao X; Tarcha P; Kissel T
Eur J Pharm Biopharm; 2012 Jan; 80(1):14-24. PubMed ID: 21924355
[TBL] [Abstract][Full Text] [Related]
11. Polymeric nanocarriers for transport modulation across the pulmonary epithelium: dendrimers, polymeric nanoparticles, and their nanoblends.
Bharatwaj B; Dimovski R; Conti DS; da Rocha SR
AAPS J; 2014 May; 16(3):522-38. PubMed ID: 24691741
[TBL] [Abstract][Full Text] [Related]
12. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles of pH-Responsive, PEG-Doxorubicin Conjugates: Interaction with an in Vitro Model of Lung Adenocarcinoma and Their Direct Formulation in Propellant-Based Portable Inhalers.
Rao KSVK; Zhong Q; Bielski ER; da Rocha SRP
Mol Pharm; 2017 Nov; 14(11):3866-3878. PubMed ID: 28972765
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
[TBL] [Abstract][Full Text] [Related]
16. GABA
Ni S; Liu Y; Tang Y; Chen J; Li S; Pu J; Han L
Carbohydr Polym; 2018 Jan; 179():135-144. PubMed ID: 29111036
[TBL] [Abstract][Full Text] [Related]
17. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.
Roche N; Dekhuijzen PN
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873
[TBL] [Abstract][Full Text] [Related]
18. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
Laube BL
Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
[TBL] [Abstract][Full Text] [Related]
19. Poly (amidoamine) (PAMAM) dendrimer mediated delivery of drug and pDNA/siRNA for cancer therapy.
Li J; Liang H; Liu J; Wang Z
Int J Pharm; 2018 Jul; 546(1-2):215-225. PubMed ID: 29787895
[TBL] [Abstract][Full Text] [Related]
20. Co-Spray Dried Mannitol/Poly(amidoamine)-Doxorubicin Dry-Powder Inhaler Formulations for Lung Adenocarcinoma: Morphology, In Vitro Evaluation, and Aerodynamic Performance.
Zhong Q
AAPS PharmSciTech; 2018 Feb; 19(2):531-540. PubMed ID: 28840529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
